These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 35740092)

  • 1. The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis.
    Lin K; Baritaki S; Vivarelli S; Falzone L; Scalisi A; Libra M; Bonavida B
    Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.
    Granados-Principal S; Liu Y; Guevara ML; Blanco E; Choi DS; Qian W; Patel T; Rodriguez AA; Cusimano J; Weiss HL; Zhao H; Landis MD; Dave B; Gross SS; Chang JC
    Breast Cancer Res; 2015 Feb; 17(1):25. PubMed ID: 25849745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women.
    Comen E; Davids M; Kirchhoff T; Hudis C; Offit K; Robson M
    Breast Cancer Res Treat; 2011 Aug; 129(1):185-90. PubMed ID: 21394499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scores.
    Evans DG; Woodward ER; Howell SJ; Verhoef S; Howell A; Lalloo F
    Fam Cancer; 2017 Apr; 16(2):173-179. PubMed ID: 27796713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screens.
    Evans DG; Lalloo F; Howell S; Verhoef S; Woodward ER; Howell A
    Breast Cancer Res Treat; 2016 Feb; 155(3):597-601. PubMed ID: 26888723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of Triple Negative Breast Cancer and the Impact of Inducible Nitric Oxide Synthase on Tumor Biology and Patient Outcomes.
    Walsh EM; Keane MM; Wink DA; Callagy G; Glynn SA
    Crit Rev Oncog; 2016; 21(5-6):333-351. PubMed ID: 29431082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and mutations of BRCA in breast cancer and ovarian cancer: Evidence from bioinformatics analyses.
    Wang Z; Zhang J; Zhang Y; Deng Q; Liang H
    Int J Mol Med; 2018 Dec; 42(6):3542-3550. PubMed ID: 30221688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families.
    Eerola H; Heinonen M; Heikkilä P; Kilpivaara O; Tamminen A; Aittomäki K; Blomqvist C; Ristimäki A; Nevanlinna H
    Breast Cancer Res; 2008; 10(1):R17. PubMed ID: 18275599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible nitric oxide synthase in heart tissue and nitric oxide in serum of Trypanosoma cruzi-infected rhesus monkeys: association with heart injury.
    Carvalho CM; Silverio JC; da Silva AA; Pereira IR; Coelho JM; Britto CC; Moreira OC; Marchevsky RS; Xavier SS; Gazzinelli RT; da Glória Bonecini-Almeida M; Lannes-Vieira J
    PLoS Negl Trop Dis; 2012; 6(5):e1644. PubMed ID: 22590660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers.
    Rizzolo P; Navazio AS; Silvestri V; Valentini V; Zelli V; Zanna I; Masala G; Bianchi S; Scarnò M; Tommasi S; Palli D; Ottini L
    Oncotarget; 2016 Nov; 7(45):74097-74106. PubMed ID: 27765917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
    Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
    Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple-negative breast cancer frequency and type of
    Palomba G; Budroni M; Olmeo N; Atzori F; Ionta MT; Pisano M; Tanda F; Cossu A; Palmieri G
    Oncol Lett; 2014 Apr; 7(4):948-952. PubMed ID: 24944648
    [TBL] [Abstract][